Bioxytran Inc. (BIXT). Dr. David Platt, CEO of new
Post# of 98044
(Total Views: 59)
Posted On: 03/25/2019 6:50:36 AM
Bioxytran Inc. (BIXT). Dr. David Platt, CEO of newly formed company Bioxytran Inc, a developmental stage biotechnology company, recently addressed his shareholders in a letter discussing the significant progress the organization has made as of late. In said letter, Platt touched on a variety of matters, including a significant company milestone; Bioxytran, Inc’s transition from a privately held, to fully reporting public company under the new stock symbol BIXT.
(0)
(0)
Scroll down for more posts ▼